title: Serotonin transporter polymorphism and fluoxetine effect on impulsiveness and aggression in borderline personality disorder.
abstract: BACKGROUND
  Impulsiveness and aggressiveness are characteristics of borderline personality disorder and are associated to a serotoninergic system dysfunction. Serotonin transporter polymorphisms have been linked to aggressive and impulsive behaviors. The short allele (S) in depression is associated to a worse response to selective serotonin reuptake inhibitors (SSRI). This study aims to study these polymorphisms to predict the response of aggressive and impulsive behaviors to SSRIs in borderline personality disorder.
  
  
  METHODS
  Fifty-nine patients with DSM-IV borderline personality disorder in accordance with the International Personality Disorder Examination (IPDE) and without axis 1 disease were treated with flexible doses of fluoxetine for 12 weeks. The patients were evaluated with the Overt Aggression Scale Modified (OAS-M) at the beginning and at 2, 4, 8 and 12 weeks of treatment. Polymorphisms L and S of the serotonin transporter promoter region were determined. Response to fluoxetine of the LL carriers versus the S carriers (LS+SS) was compared.
  
  
  RESULTS
  LL carriers had a better response than S carriers in the reduction of total OAS-M scores and on the aggressiveness and irritability components of the OAS-M.
  
  
  CONCLUSIONS
  L-allele carriers responded better to fluoxetine than S carriers, in a similar way as in depression. The S allele may represent a common factor of bad response to SSRI in diseases associated to serotoninergic system dysfunction.
authors.affiliation: Clínica Psiquiátrica Universitaria, Hospital Clínico, Universidad de Chile. hsilva@med.uchile.cl
authors.forename: H
authors.initials: H
authors.lastname: Silva
authors.forename: P
authors.initials: P
authors.lastname: Iturra
authors.forename: A
authors.initials: A
authors.lastname: Solari
authors.forename: J
authors.initials: J
authors.lastname: Villarroel
authors.forename: S
authors.initials: S
authors.lastname: Jerez
authors.forename: W
authors.initials: W
authors.lastname: Vielma
authors.forename: C
authors.initials: C
authors.lastname: Montes
authors.forename: L
authors.initials: L
authors.lastname: Pumarino
authors.forename: N
authors.initials: N
authors.lastname: Roa
mesh_terms: D000293:Adolescent; D000328:Adult; D000374:Aggression / Q000187:drug effects*; D001883:Borderline Personality Disorder / Q000188:drug therapy* / Q000235:genetics*; D005260:Female; D005473:Fluoxetine / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D007175:Impulsive Behavior / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic / Q000235:genetics*; D050486:Serotonin Plasma Membrane Transport Proteins / Q000235:genetics*; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*
chemical_list: D005473:Fluoxetine; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors